These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5561404)

  • 1. [Stability of acetylsalicylic acid in dosage forms].
    Rak J; Chalabala M
    Cesk Farm; 1971; 20(4):154-60. PubMed ID: 5561404
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 3. On the stability of a nicotinamido-methylaminopyrazolone (Ra 101).
    Banci F; Del Grande P; Monai A
    Arzneimittelforschung; 1970 Aug; 20(8):1030-2. PubMed ID: 5536495
    [No Abstract]   [Full Text] [Related]  

  • 4. [Formulation of effervescent tablets containing acetylsalicylic acid. III. Investigation of the stability of the active principles of tablets].
    Dévay A; Kovács P; Rácz I
    Acta Pharm Hung; 1989 Jan; 59(1):11-5. PubMed ID: 2711837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation studies of azithromycin and its spectrophotometric determination in pharmaceutical dosage forms.
    Sultana N; Arayne MS; Hussain F; Fatima A
    Pak J Pharm Sci; 2006 Apr; 19(2):98-103. PubMed ID: 16751118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stabilization of acetylsalicylic acid in solid drug forms. 3. Effect of coating method and coating materials on the stability of the acetylsalicylic acid].
    Stozek T; Krówczyński L
    Acta Pol Pharm; 1973 Oct; 30(5):527-32. PubMed ID: 4764194
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-enzymic browning in solid-dosage forms: lactose-induced discoloration of neomycin tablets.
    Hammouda Y; Salakawy SA
    Pharmazie; 1971 Oct; 26(10):636-40. PubMed ID: 5149136
    [No Abstract]   [Full Text] [Related]  

  • 8. Biopharmaceutical aspects of the design of steroidal dosage forms.
    Short MP; Rhodes CT
    Pharmazie; 1973 Aug; 28(8):509-13. PubMed ID: 4593892
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of adjuvants on the dissolution rate and stability of acetylsalicylic acid in tablets. 3. Effect of surface-active agents].
    Cid E; Jaminet F
    J Pharm Belg; 1971; 26(4):369-74. PubMed ID: 5142948
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of adjuvants on the dissolution rate and stability of acetylsalicylic acid in tablets. II. Effect of lubrication agents].
    Cid E; Jaminet F
    J Pharm Belg; 1971; 26(4):360-8. PubMed ID: 5142947
    [No Abstract]   [Full Text] [Related]  

  • 11. [Liquid drug form with acetylsalicylic acid].
    Minkov E; Natscheva R; Nedeleva L
    Pharmazie; 1969 Dec; 24(12):770-2. PubMed ID: 5387470
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the thermic stability of drug solutions].
    Speiser P
    Pharm Acta Helv; 1968 Nov; 43(11):693-703. PubMed ID: 4888331
    [No Abstract]   [Full Text] [Related]  

  • 13. Stability of sodium ampicillin in aqueous solutions.
    Hiranaka PK; Frazier AG; Gallelli JF
    Am J Hosp Pharm; 1972 Apr; 29(4):321-2. PubMed ID: 5025262
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of the chemical stability of acetylsalicylic acid tablets during storage in pharmacies of Concepción, Chile].
    Mennickent S; Yates T; Vega M; Gloria Godoy C; Saelzer R
    Rev Med Chil; 2002 Apr; 130(4):409-15. PubMed ID: 12090106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stabilization of acetylsalicylic acid in solid drug form. IV. Effect of coating on the dissolving rate of acetylsalicylic acid in pure substance and in tablets].
    Stozek T; Krówczyński L
    Acta Pol Pharm; 1973; 30(6):597-604. PubMed ID: 4775909
    [No Abstract]   [Full Text] [Related]  

  • 16. [Stability of acetylsalicylic acid base tablets in tropical environment].
    Delonca H; Thai TT; Galen ML; Laget JP
    Pharm Acta Helv; 1972; 47(3):199-208. PubMed ID: 5031926
    [No Abstract]   [Full Text] [Related]  

  • 17. The construction and uses of factorial designs in the preparation of solid dosage forms. Part 1: Effervescent acetylsalicylic acid tablets.
    El-Banna HM; Minina SA
    Pharmazie; 1981 Jun; 36(6):417-20. PubMed ID: 7279987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical heterogeneous system. IV. A kinetic approach to the stability screening of solid dosage forms containing aspirin.
    Maulding HV; Zoglio MA; Pigois FE; Wagner M
    J Pharm Sci; 1969 Nov; 58(11):1359-62. PubMed ID: 5349749
    [No Abstract]   [Full Text] [Related]  

  • 19. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
    Sosnowska K; Winnicka K; Czajkowska-Kośnik A
    Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of the compression force on the dimension of particles of acetylsalicylic acid and their rapidity of dissolution].
    Cid E; Jaminet F
    Pharm Acta Helv; 1971 Mar; 46(3):167-78. PubMed ID: 5550120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.